CENTESSA PHARMACEUTICALS PLC's ticker is CNTA and the CUSIP is 152309100. A total of 51 filers reported holding CENTESSA PHARMACEUTICALS PLC in Q3 2023. The put-call ratio across all filers is 0.08 and the average weighting 2.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,986,481 | +64283.2% | 770,708 | -38.4% | 0.26% | -26.2% |
| Q2 2023 | $7,745 | +60.8% | 1,251,137 | 0.0% | 0.36% | +51.5% |
| Q1 2023 | $4,817 | -100.0% | 1,251,137 | 0.0% | 0.24% | -88.4% |
| Q4 2022 | $38,785,245 | +671.1% | 1,251,137 | 0.0% | 2.04% | +622.6% |
| Q3 2022 | $5,030,000 | -17.4% | 1,251,137 | 0.0% | 0.28% | -26.7% |
| Q2 2022 | $6,093,000 | -46.0% | 1,251,137 | 0.0% | 0.39% | -33.3% |
| Q1 2022 | $11,273,000 | -20.0% | 1,251,137 | 0.0% | 0.58% | +5.9% |
| Q4 2021 | $14,088,000 | -36.8% | 1,251,137 | -6.2% | 0.55% | -29.7% |
| Q3 2021 | $22,282,000 | +10.9% | 1,334,227 | +47.6% | 0.78% | +9.7% |
| Q2 2021 | $20,083,000 | – | 904,227 | – | 0.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 17,923,892 | $299,329,000 | 65.12% |
| Vida Ventures Advisors, LLC | 3,931,818 | $65,661,000 | 18.81% |
| Samsara BioCapital, LLC | 1,537,533 | $25,677,000 | 4.03% |
| VR Adviser, LLC | 1,127,272 | $18,825,000 | 2.42% |
| Logos Global Management LP | 1,069,545 | $17,861,000 | 1.29% |
| Cormorant Asset Management, LP | 1,727,273 | $28,724,000 | 1.17% |
| GENERAL ATLANTIC, L.P. | 9,681,818 | $161,686,000 | 0.95% |
| Affinity Asset Advisors, LLC | 203,183 | $3,393,000 | 0.86% |
| RA Capital Management | 3,577,094 | $59,737,000 | 0.83% |
| Boxer Capital, LLC | 1,334,227 | $22,282,000 | 0.78% |